|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/4965 | (2006.01) |
| A61K 31/497 | (2006.01) | ||
| A61P 7/06 | (2006.01) |
| (11) | Number of the document | 3406251 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18166225.5 |
| Date of filing the European patent application | 2012-05-03 | |
| (97) | Date of publication of the European application | 2018-11-28 |
| (45) | Date of publication and mention of the grant of the patent | 2023-11-29 |
| (46) | Date of publication of the claims translation | 2024-02-12 |
| (30) | Number | Date | Country code |
| 201161482171 P | 2011-05-03 | US |
| (72) |
SU, Shin-San Michael , US
DANG, Lenny , US
|
| (73) |
Agios Pharmaceuticals, Inc. ,
88 Sidney Street, Cambridge, MA 02139,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Piruvatkinazės aktyvatoriai, skirti panaudoti terapijai |
| PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY |
| Payment date | Validity (years) | Amount | |
| 2025-04-22 | 14 | 289.00 EUR |
| 2026-05-03 |